⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880538 | 0.81 | SLC22A6 (0.30) | — | |
| SCHEMBL11324359 | 0.78 | SLC22A6 (0.33) | — | |
| SCHEMBL4397485 | 0.78 | — | — | |
| SCHEMBL21494138 | 0.75 | TSHR (0.34) | — | |
| SCHEMBL31473010 | 0.74 | SLC22A6 (0.33) | — | |
| SCHEMBL23859620 | 0.73 | RAB9A (0.36) | — | |
| SCHEMBL31033120 | 0.73 | RAB9A (0.36) | — | |
| SCHEMBL7101332 | 0.73 | RAB9A (0.36) | — | |
| SCHEMBL167450 | 0.73 | RAB9A (0.36) | — | |
| SCHEMBL353716 | 0.72 | KDM4E (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4228636-A1 | COMPOSITIONS AND METHODS FOR STORAGE STABLE OPHTHALMIC DRUGS | Lenz Therapeutics, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022081204-A1 | COMPOSITIONS AND METHODS FOR STORAGE STABLE OPHTHALMIC DRUGS | PRESBYOPIA THERAPIES, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| EP-0507854-A4 | METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN | — | 1992-10-21 | — | — | EP | disclosed |
| EP-0507854-A1 | METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN. | SYMEX CORP (US) | 1992-10-14 | — | — | EP | disclosed |
| WO-1991009972-A1 | METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | disclosed |
| WO-1991009975-A1 | CHROMOGENIC 7- OR 8-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | disclosed |